MD1629G2 - Метод предупреждения сальмонелеза - Google Patents
Метод предупреждения сальмонелеза Download PDFInfo
- Publication number
- MD1629G2 MD1629G2 MDA20000079A MD20000079A MD1629G2 MD 1629 G2 MD1629 G2 MD 1629G2 MD A20000079 A MDA20000079 A MD A20000079A MD 20000079 A MD20000079 A MD 20000079A MD 1629 G2 MD1629 G2 MD 1629G2
- Authority
- MD
- Moldova
- Prior art keywords
- salmonellosis
- enterosorbent
- prevention
- administration
- invention consists
- Prior art date
Links
- 206010039438 Salmonella Infections Diseases 0.000 title abstract 3
- 206010039447 salmonellosis Diseases 0.000 title abstract 3
- 230000002265 prevention Effects 0.000 title abstract 2
- 239000006185 dispersion Substances 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 235000013399 edible fruits Nutrition 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 239000011148 porous material Substances 0.000 abstract 1
- 239000004575 stone Substances 0.000 abstract 1
- 231100000331 toxic Toxicity 0.000 abstract 1
- 230000002588 toxic effect Effects 0.000 abstract 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Farming Of Fish And Shellfish (AREA)
Abstract
Изобретение относится к медицине, в частности к методу предупреждения сальмонелеза.Сущность изобретения состоит в введении энтеросорбента, полученного из твердой оболочки фруктовых косточек, которое осуществляют одноразово в первый день после инфекции в дозе 400 мг/кг химически активированного энтеросорбента, со степенью дисперсии 0,25…1,0 мм и общим объемом пор 0,76…1,24 см3/г.Результат изобретения состоит в уменьшении токсических проявлений сальмонелеза после применения энтеросорбента.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000079A MD1629G2 (ru) | 2000-04-26 | 2000-04-26 | Метод предупреждения сальмонелеза |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MDA20000079A MD1629G2 (ru) | 2000-04-26 | 2000-04-26 | Метод предупреждения сальмонелеза |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MD1629F1 MD1629F1 (en) | 2001-03-31 |
| MD1629G2 true MD1629G2 (ru) | 2001-09-30 |
Family
ID=19739590
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MDA20000079A MD1629G2 (ru) | 2000-04-26 | 2000-04-26 | Метод предупреждения сальмонелеза |
Country Status (1)
| Country | Link |
|---|---|
| MD (1) | MD1629G2 (ru) |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD587C2 (ru) * | 1995-06-12 | 1997-03-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Адсорбирующее вещество "Карбасан" |
-
2000
- 2000-04-26 MD MDA20000079A patent/MD1629G2/ru not_active IP Right Cessation
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MD587C2 (ru) * | 1995-06-12 | 1997-03-31 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Адсорбирующее вещество "Карбасан" |
Non-Patent Citations (1)
| Title |
|---|
| Л.Г., Григорьев А.В., Знаменский В.А., Ковальчук В.К., Алексеенко Е.П., Экспериментальное изучение активности энтеросорбентов при сальмонелезе, * |
Also Published As
| Publication number | Publication date |
|---|---|
| MD1629F1 (en) | 2001-03-31 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG52240A1 (en) | The use of cetrorelix and other nona-and decapeptides in the preparation of a medicament for combating aids and for growth stimulation | |
| WO2001078698A3 (en) | Use of ngf-antagonists for the prevention or treatment of chronic visceral pain | |
| EP1600168A3 (en) | A pyrrolidineacetamide derivative alone or in combination for treatment of CNS disorder | |
| AU2003274071A1 (en) | Dosage form that is safeguarded from abuse | |
| NO993520D0 (no) | Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon | |
| WO2002089778A3 (en) | Transdermal therapeutic system for parkinson's disease inducing high plasma levels of rotigotine | |
| EP2138175A3 (en) | Formulations comprising valsartan for treating diabetes or microalbuminuria | |
| WO2001076601A3 (en) | Pharmaceutical compositions comprising salmeterol and ipratropium | |
| AP2049A (en) | Medicament containing activated antithrombin III | |
| EP1806144A3 (en) | Use of SARP-1 for the treatment and/or prevention of scleroderma | |
| PL368686A1 (en) | Novel aminobenzoephenones | |
| YU29804A (sh) | Upotreba aktivatora gp-130 u dijabetskoj neuropatiji | |
| MD1629G2 (ru) | Метод предупреждения сальмонелеза | |
| WO2004012732A3 (en) | Use of a proteasome inhibitor in the treatment of endothelial dysfunction and/or in a low-dose proteasome inhibitor therapy | |
| IL160486A0 (en) | Citalopram for the treatment of elevated blood pressure | |
| MXPA05011249A (es) | Combinaciones de desoxipeganina y mecamilamina para el tratamiento del abuso de alcohol. | |
| AU2002225097A1 (en) | Novel therapeutic use of a thienylcyclohexylamine derivative | |
| MXPA01008491A (es) | Mezcla terapeuticamente activa de sustancias que contienen s-acetil glutation y aciclovir. | |
| MD1609F1 (en) | Method of the recidivating chronic aphthous stomatitis treatment | |
| MD1611F1 (en) | Antibacterial and antifungal remedy | |
| EP1661566A3 (en) | Use of beta-sheet mimetics as protease and kinase inhibitors and as inhibitors of transcription factors | |
| WO2003059343A3 (en) | Drug compositions with indole alkaloids for the treatment of aids | |
| MD1580G2 (ru) | Антимутагенный агент | |
| MD1919F2 (en) | Medicinal remedy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KA4A | Patent for invention lapsed due to non-payment of fees (with right of restoration) | ||
| MM4A | Patent for invention definitely lapsed due to non-payment of fees |